ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
This article is part of the Research TopicThe Last Line of Defense: A One Health Perspective on the Spread, Molecular Mechanisms, and Novel Strategies of Last-Resort Drug ResistanceView all articles
Genomic insights into multidrug resistance in clinical Escherichia albertii: plasmid coexistence, intI1 prevalence, and interspecies dissemination risk
Provisionally accepted
- 1National Institute for Communicable Disease Control and Prevention (China CDC), Beijing, China
- 2Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China
- 3The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- 4Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Escherichia albertii (E. albertii) is an emerging foodborne pathogen of growing clinical significance and increasing multidrug resistance (MDR). This study characterized the multidrug-resistant clinical strain E. albertii ESA311 to uncover the genetic basis of its resistance and the transmission potential of its mobile genetic elements. Methods: We performed whole-genome sequencing on strain ESA311 to identify plasmids, resistance genes, and virulence factors. Conjugation experiments were conducted to evaluate plasmid transferability. Phylogenetic analysis of the MDR plasmids elucidated their evolutionary history and geographical distribution. The prevalence of intI1 and its correlation with MDR were analyzed across 160 clinical E. albertii isolates. Results: Whole-genome sequencing identified five plasmids coexisting in ESA311, with pESA311_1 and pESA311_2 harboring diverse antimicrobial resistance genes (ARGs) conferring resistance over ten antibiotic classes, facilitated by mobile genetic elements including insertion sequences (ISs) and a class 1 integron (intI1). Conjugation assays revealed a stable co-transfer consortium of pESA311_1, pESA311_2, and pESA311_5, driving concurrent dissemination of multidrug resistance and virulence (sporadically co-mobilize of pESA311_4) and posing a co-selection risk. Further phylogenetic analysis identified homologous plasmids in other species, such as Salmonella enterica and Escherichia coli. Whereas the pESA311_1 lineage is largely restricted to China, pESA311_2 homologs have dispersed more broadly across different regions. In a broader surveillance of 160 clinical E. albertii isolates, intI1 prevalence was 19.8% and strongly correlated with MDR. This is a provisional file, not the final typeset article Conclusion: Our findings establish plasmids and intI1 as pivotal drivers of MDR in E. albertii, and highlight the associated risks of resistance-virulence co-selection and interspecies plasmid dissemination.
Keywords: antimicrobial resistance, Class I integron, conjugative plasmids, Escherichia albertii, Plasmid evolution
Received: 31 Dec 2025; Accepted: 02 Feb 2026.
Copyright: © 2026 Zhang, Yang, Liu, Sui, Zhang and Xiong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yanwen Xiong
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.